Single Use Bioprocessing Market Report 2026

The single use bioprocessing market size has grown exponentially in recent years. It will grow from $31.94 billion in 2025 to $38.62 billion in 2026 at a compound annual growth rate (CAGR) of 20.9%. The growth in the historic period can be attributed to traditional stainless steel systems limitations, high capital investment, increasing biologics demand, early adoption in pilot-scale manufacturing, need for sterile production.

The single use bioprocessing market size is expected to see exponential growth in the next few years. It will grow to $81.97 billion in 2030 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to expansion in large-scale biologics production, adoption in gene and cell therapy, integration with automation and digital monitoring, growth in modular and flexible systems, increasing demand for cost-efficient single-use solutions. Major trends in the forecast period include integration with continuous manufacturing, adoption in vaccine production, rise in modular bioprocessing systems, use in clinical trial production, increasing regulatory compliance for single-use systems.

The growing demand for biopharmaceuticals is expected to drive the expansion of the single-use bioprocessing market in the coming years. Biopharmaceuticals are therapeutic products derived from living cells or organisms. Single-use bioprocessing systems are widely adopted in biopharmaceutical manufacturing as they enhance productivity, reduce operational costs, and enable safer and more efficient waste disposal. For example, in January 2024, IQVIA, a US-based provider of biopharmaceutical development services, reported that global spending on biotechnology is projected to surpass $892 billion by 2028. Therefore, the rising demand for biopharmaceuticals is fueling the growth of the single-use bioprocessing market.

Major companies operating in the single-use bioprocessing market are emphasizing innovation through advanced products, such as single-use process container films, to strengthen their technological capabilities and gain a competitive edge. The Ultimus single-use process container film, integrated into Mobius 3D process containers, delivers approximately ten times greater abrasion resistance compared with conventional single-use bioprocessing films. For instance, in April 2023, Merck Group, a Germany-based science and technology company, introduced its Single-Use Process Container Film designed to provide superior durability and leak resistance for bioprocessing liquid applications. The Ultimus film incorporates a distinctive woven nylon structure that enhances bag strength, durability, and resistance to abrasions, tears, and material fatigue. In addition, it features an animal-origin-free contact resin with low extractables, supporting reliable cell growth performance.

In May 2024, Novo Holdings A/S, a Denmark-based investment company, acquired a 60% majority stake in Single Use Support GmbH for an undisclosed amount. Through this acquisition, Novo Holdings aims to reinforce its manufacturing capabilities and supply chain, particularly in support of its pharmaceutical subsidiary. Single Use Support GmbH is an Austria-based life sciences tools company that provides single-use bioprocessing products.

Major companies operating in the single use bioprocessing market are GE Healthcare Technologies Ltd, Eppendorf AG, Corning Incorporated, Thermo Fisher Scientific Inc, Sartorius AG, JM BioConnect BV, Merck KGaA, Pall Corporation, PBS Biotech Inc, Entegris Inc, DistriCell Inc, ABEC Inc, Solida Biotech GmbH, OmniBRx Biotechnologies Pvt Ltd, Celltainer Biotech BV, Cellexus BV, Danaher Corporation, Repligen Corporation, Lonza Group Ltd, Meissner Filtration Products Inc, MilliporeSigma, Avantor Performance Materials India Limited, Saint-Gobain Performance Plastics Corp, Rentschler Biopharma SE, Charter Medical Inc, Sollesis Medical Plc, Catalent Inc, Patheon Inc.

North America was the largest region in the single-use bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single use bioprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single use bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have raised costs in the single use bioprocessing market by increasing prices for imported plastic bioreactors, tubing sets, filtration devices, and gamma-sterilized components. Biopharmaceutical companies and contract manufacturing organizations in Asia-Pacific and Europe are most affected due to global sourcing of critical consumables. These higher input costs can impact biologics production efficiency. However, tariffs are encouraging regional manufacturing of single-use systems, enhancing supply security and scalability in the single use bioprocessing market.

The single use bioprocessing market research report is one of a series of new reports that provides single use bioprocessing market statistics, including single use bioprocessing industry global market size, regional shares, competitors with a single use bioprocessing market share, detailed single use bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the single use bioprocessing industry. This single use bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Single-use bioprocessing involves bioprocessing equipment that is intended for one-time use and then disposed of after use. These systems are typically made from plastic components and sterilized using gamma radiation. They help reduce cleaning requirements, as well as water and energy consumption, and are used across the bioproduction workflow while minimizing the risk of cross-contamination.

The main product types in the single-use bioprocessing market include single-use media bags and containers, single-use assemblies, single-use bioreactors, disposable mixers, and others. Single-use media bags and containers are designed to hold sterile media, cell cultures, sera, buffers, and reagents, and are used once before being discarded. The workflows supported include upstream processing, fermentation, and downstream processing. Applications include filtration, storage, cell culture, mixing, and purification, and these products are used by biopharmaceutical and pharmaceutical companies, contract research organizations and contract manufacturing organizations (CROs and CMOs), as well as academic and research institutes.

The single-use bioprocessing market includes revenues earned by entities by bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags and containers, mixing systems, tubing assemblies and sampling systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.